Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2182590 | 0.96 | — | — | |
| SCHEMBL2184233 | 0.89 | — | — | |
| SCHEMBL4492651 | 0.84 | HRH4 (0.38) | HRH4HRH3KDM4EMEN1ALDH1A1 | |
| SCHEMBL694780 | 0.79 | HRH4 (0.38) | HRH4HRH3KDM4EMEN1ALDH1A1 | |
| SCHEMBL15031168 | 0.77 | HRH3 (0.47) | HRH4HRH3KDM4EMEN1ALDH1A1 | |
| SCHEMBL14817555 | 0.77 | HRH3 (0.47) | HRH4HRH3KDM4EMEN1ALDH1A1 | |
| SCHEMBL620016 | 0.77 | KDM4E (0.49) | KDM4EMEN1ALDH1A1KMT2ANPC1 | |
| SCHEMBL24537399 | 0.76 | KDM4E (0.47) | KDM4EMEN1ALDH1A1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL2140316 | 0.76 | KDM4E (0.47) | KDM4EMEN1ALDH1A1KMT2ANPC1 | |
| SCHEMBL17046065 | 0.76 | KDM4E (0.47) | KDM4EMEN1ALDH1A1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306368-A1 | POLYNUCLEAR COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-2093227-A1 | POLYNUCLEAR COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2009-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306368-A1 | POLYNUCLEAR COMPLEX | AP2M1, HNRNPH3, NDUFC2 | HRH4 791/4885HRH3 234/4885KDM4E 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.